Deal net: 6 – 10 February 2017

The Global Government Venturing deal net rounds up all the latest smaller deals and tracks emerging companies accessing government funds.

Atriva Therapeutics, a Germany-based developer of antiviral therapies, has received an undisclosed amount in seed funding co-led by public-private partnership High-Tech Gründerfonds and Stichting Participatie Artriva. A range of private investors also participated in the round, which will support the advancement of the startup’s therapy for influenza into the clinical development stage.

See more from this Government Report: Germany

Back

Copyright Mawsonia Limited 2010. Please don't cut articles from www.globalgovernmentventuring.com or the PDF and redistribute by email or post to the web without written permission.

Most read

  1. HTGF conference scouts innovation, finds cooperation

    February 06, 2017

  2. Iyzico gets IFC backing to raise $13m

    January 24, 2017

  3. China switches on $14.5bn internet fund

    January 25, 2017

  4. Editorial: GGV launches Leadership Society

    January 30, 2017

  5. Personal MedSystems beats its way to series B

    January 26, 2017

Events

  • 23 May - 24 May, 2017

    GCV Symposium 2017 - London

    Join 400+ business leaders from the corporate venturing and wider high growth business ecosystem for the two-day 2017 GCV Symposium.

  • More Events